How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?

Glucagonomas are neuroendocrine tumors (NETs) that arise from the alpha cells of the pancreatic islets. They are typically slow-growing tumors associated with abnormal glucagon secretion, resulting in one or more non-specific clinical features, such as necrolytic migratory erythema (NME), diabetes,...

Full description

Bibliographic Details
Main Authors: Carmen Sorina Martin, Ovidiu Dumitru Parfeni, Liliana Gabriela Popa, Mara Madalina Mihai, Dana Terzea, Vlad Herlea, Mirela Gherghe, Razvan Adam, Osama Alnuaimi, Valentin Calu, Adrian Miron, Silvius Negoita, Cornelia Nitipir, Simona Fica
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/1/216
_version_ 1827665943057137664
author Carmen Sorina Martin
Ovidiu Dumitru Parfeni
Liliana Gabriela Popa
Mara Madalina Mihai
Dana Terzea
Vlad Herlea
Mirela Gherghe
Razvan Adam
Osama Alnuaimi
Valentin Calu
Adrian Miron
Silvius Negoita
Cornelia Nitipir
Simona Fica
author_facet Carmen Sorina Martin
Ovidiu Dumitru Parfeni
Liliana Gabriela Popa
Mara Madalina Mihai
Dana Terzea
Vlad Herlea
Mirela Gherghe
Razvan Adam
Osama Alnuaimi
Valentin Calu
Adrian Miron
Silvius Negoita
Cornelia Nitipir
Simona Fica
author_sort Carmen Sorina Martin
collection DOAJ
description Glucagonomas are neuroendocrine tumors (NETs) that arise from the alpha cells of the pancreatic islets. They are typically slow-growing tumors associated with abnormal glucagon secretion, resulting in one or more non-specific clinical features, such as necrolytic migratory erythema (NME), diabetes, diarrhea, deep vein thrombosis, weight loss, and depression. Here, we report the case of a 44-year-old male with a history of diabetes mellitus, presenting with a pruritic and painful disseminated cutaneous eruption of erythematous plaques, with scales and peripheral pustules, misdiagnosed as disseminated pustular psoriasis and treated for 2 years with oral retinoid and glucocorticoids. During this period, the patient complained of weight loss of 32 kg and diarrhea and developed deep vein thrombosis. These symptoms, together with an inadequate response to therapy of the skin lesions, led to the reassessment of the initial diagnosis. Laboratory tests confirmed elevated plasma glucagon levels (>1000 pg/mL) and computed tomography (CT) scans revealed a 35/44 mm tumor in the pancreatic tail. Due to considerable disease complications and the COVID-19 pandemic, the surgical removal of the tumor was delayed for nearly 2 years. During this time, somatostatin analogue therapy efficiently controlled the glucagonoma syndrome and likely prevented tumor progression. As in other functional pancreatic NETs, the early clinical recognition of hormonal hypersecretion syndrome and the multidisciplinary approach are the keys for best patient management.
first_indexed 2024-03-10T01:37:06Z
format Article
id doaj.art-09b9792092184d8a9f7754b945b65c09
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T01:37:06Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-09b9792092184d8a9f7754b945b65c092023-11-23T13:30:15ZengMDPI AGDiagnostics2075-44182022-01-0112121610.3390/diagnostics12010216How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?Carmen Sorina Martin0Ovidiu Dumitru Parfeni1Liliana Gabriela Popa2Mara Madalina Mihai3Dana Terzea4Vlad Herlea5Mirela Gherghe6Razvan Adam7Osama Alnuaimi8Valentin Calu9Adrian Miron10Silvius Negoita11Cornelia Nitipir12Simona Fica13Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Elias Emergency University Hospital, 011461 Bucharest, RomaniaDepartment of Oncological Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Oncological Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaOncoTeam Diagnostic, 030138 Bucharest, RomaniaDepartment of Pathology, Fundeni Clinical Institute, 022328 Bucharest, RomaniaDepartment of Radiology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Firs Aid and Disaster Medicine, Titu Maiorescu University, 040051 Bucharest, RomaniaDepartment of Radiology, Elias Emergency University Hospital, 011461 Bucharest, RomaniaDepartment of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Surgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Anaesthesia and Intensive Care, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Oncology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaGlucagonomas are neuroendocrine tumors (NETs) that arise from the alpha cells of the pancreatic islets. They are typically slow-growing tumors associated with abnormal glucagon secretion, resulting in one or more non-specific clinical features, such as necrolytic migratory erythema (NME), diabetes, diarrhea, deep vein thrombosis, weight loss, and depression. Here, we report the case of a 44-year-old male with a history of diabetes mellitus, presenting with a pruritic and painful disseminated cutaneous eruption of erythematous plaques, with scales and peripheral pustules, misdiagnosed as disseminated pustular psoriasis and treated for 2 years with oral retinoid and glucocorticoids. During this period, the patient complained of weight loss of 32 kg and diarrhea and developed deep vein thrombosis. These symptoms, together with an inadequate response to therapy of the skin lesions, led to the reassessment of the initial diagnosis. Laboratory tests confirmed elevated plasma glucagon levels (>1000 pg/mL) and computed tomography (CT) scans revealed a 35/44 mm tumor in the pancreatic tail. Due to considerable disease complications and the COVID-19 pandemic, the surgical removal of the tumor was delayed for nearly 2 years. During this time, somatostatin analogue therapy efficiently controlled the glucagonoma syndrome and likely prevented tumor progression. As in other functional pancreatic NETs, the early clinical recognition of hormonal hypersecretion syndrome and the multidisciplinary approach are the keys for best patient management.https://www.mdpi.com/2075-4418/12/1/216neuroendocrine tumorglucagonglucagonomasomatostatin analoguesnecrolytic migratory erythema
spellingShingle Carmen Sorina Martin
Ovidiu Dumitru Parfeni
Liliana Gabriela Popa
Mara Madalina Mihai
Dana Terzea
Vlad Herlea
Mirela Gherghe
Razvan Adam
Osama Alnuaimi
Valentin Calu
Adrian Miron
Silvius Negoita
Cornelia Nitipir
Simona Fica
How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
Diagnostics
neuroendocrine tumor
glucagon
glucagonoma
somatostatin analogues
necrolytic migratory erythema
title How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
title_full How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
title_fullStr How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
title_full_unstemmed How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
title_short How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
title_sort how many times can one go back to the drawing board before the accurate diagnosis and surgical treatment of glucagonoma
topic neuroendocrine tumor
glucagon
glucagonoma
somatostatin analogues
necrolytic migratory erythema
url https://www.mdpi.com/2075-4418/12/1/216
work_keys_str_mv AT carmensorinamartin howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT ovidiudumitruparfeni howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT lilianagabrielapopa howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT maramadalinamihai howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT danaterzea howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT vladherlea howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT mirelagherghe howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT razvanadam howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT osamaalnuaimi howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT valentincalu howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT adrianmiron howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT silviusnegoita howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT cornelianitipir howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma
AT simonafica howmanytimescanonegobacktothedrawingboardbeforetheaccuratediagnosisandsurgicaltreatmentofglucagonoma